Patent Yard Sign in
Expired Canadian patentCanada

Multimer sample pretreatment and immunoassay without boiling, for total adiponectin assessment

CA 2542825 C · Owner: Toudai Tlo, Ltd. · Inventors: Ebinuma, Hiroyuki; Akimoto, Yuka; Kadowaki, Takashi

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention provides a method of pretreating a sample for conveniently, quickly and accurately measuring the total amount of adiponectin present in a biological sample contaminated with various adiponectin multimers. The method of measuring an sample for immunologically assaying the total amount of adiponectin present in the sample comprises reacting, with an adiponectin-containing sample, at least one of a reducing agent an acid or a salt , thereof, a surfactant and a protease.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 15, 2004 and granted June 19, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 15, 2024.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 15, 2026.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 15, 2004
GrantedJune 19, 2012
Term endedOctober 15, 2024
Patent numberCA 2542825 C
Classification (IPC)G01N33/53

Timeline

Timeline From CIPO dates

2005200720092011201320152017201920212023Application filedOct 15, 2004Patent grantedJune 19, 2012Term endedOct 15, 2024

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.